LZLiying Zhu

Liying Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liying Zhu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Chengcheng Li

    School of Public Health, Guizhou Medical University, Guiyang, Guizhou 561113, PR China; Guizhou Prenatal Diagnosis Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China

    6 shared publications
  • Haizhi Li

    Reproductive Centre, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China

    3 shared publications
  • Nenghong Yang

    Affiliated Hospital of Guizhou Medical University Guizhou Medical University Guiyang China

    3 shared publications
  • Wei Pan

    Department of Medical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    3 shared publications
  • Wei Pan

    Prenatal Diagnosis Center in Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang, China

    3 shared publications
  • Xing Li

    Department of Medical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    3 shared publications

Latest Publications

  • Open Access

    Network toxicology and machine learning revealed the association between non-alcoholic fatty liver disease induced by polystyrene nanoplastics

    by Yiqiong Zhang, Yachun Shi, Huiru Yang, Haizhi Li, Chengcheng Li, Mi Liu, Yinxue Zhong, Changyudong Huang, Liying Zhu, Yongjie Xu, et al.


  • Open Access

    Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications

    by Yongjie Xu, Di Chen, Huiru Yang, Yiqiong Zhang, Changyudong Huang, Yinxue Zhong, Haizhi Li, Liying Zhu, Chengcheng Li, Rui Yan, et al.

    Emerging evidence indicates a critical link between diabetic complications and the interplay of glycemic variability and gut microbiota metabolic activity. This review comprehensively examines the regulatory effects of glycemic fluctuations on the composition and function of the gut microbiota, while elucidating the key mechanisms by which microbial metabolic reprogramming—mediated through short‐chain fatty acids, bile acids, and other metabolites—disrupts host metabolic and immune homeostasis, thereby exacerbating diabetic complications. Research demonstrates that glycemic variability not only directly contributes to vascular and neuronal damage but also remodels the gut microbiota's metabolic network, triggering systemic metabolic dysregulation and chronic low‐grade inflammation. Building on these findings, we explore novel therapeutic strategies targeting the gut microbiota for the prevention and management of diabetic complications. By adopting a “gut‐organ axis” framework, this study unveils the cascade of interactions among glycemic variability, gut microbiota, and metabolic disturbances in the pathogenesis of diabetic complications, offering both theoretical foundations and innovative approaches for clinical intervention.


  • Open Access

    Near-infrared spectroscopy of blood plasma amino acids with chemometrics towards breast cancer discrimination

    by Liying Zhu, Haizhi Li, Wen Qian, Chengcheng Li, Changyudong Huang, Yiqiong Zhang, Yunfeng Duan, Shuang Wang, Yongjie Xu, Jingzhi Zhang, et al.


  • Open Access

    Application of Serum Mid‐Infrared Spectroscopy Combined with Machine Learning in Rapid Screening of Breast Cancer and Lung Cancer

    by Kejing Zhu, Jie Shen, Wen Xu, Keyu Yue, Liying Zhu, Yulin Niu, Qing Wu, Wei Pan

    Cancer is an increasing burden on global health. Breast and lung cancers are the two tumors with the highest incidence rates. The study shows that early detection and early diagnosis are important prognostic factors for breast and lung cancers. Due to the great advantages of artificial intelligence in feature extraction, the combination of infrared analysis technology may have great potential in clinical applications. This study explores the potential application of mid‐infrared spectroscopy combined with machine learning for the differentiation of breast and lung cancers. The experiment collects blood samples from clinical sources, separates serum, trains classification models, and finally predicts unknown sample categories. We use k‐fold cross‐validation to determine the training set of 301 cases and the test set of 50 cases. Through differential spectrum analysis, we found that the intervals of 1318.59–1401.03 cm−1, 1492.15–1583.27 cm−1, and 1597.25–1721.64 cm−1 have significant differences, which may reflect the absorption of key chemical bonds in protein molecules. We use a total of 24 models such as decision trees, discriminant analysis, support vector machines, and K‐nearest neighbor to train, identify, and distinguish spectra. The results show that under the same conditions, the prediction model trained based on fine KNN has the best performance and can perform 100% prediction on the test set samples. This also shows that our model has important potential for auxiliary diagnosis of serum breast cancer and lung cancer. This method may help to further achieve comprehensive screening of associated cancers in underserved areas, thereby reducing the cancer burden through early detection of cancer and appropriate treatment and care of cancer patients.


  • Open Access

    Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway

    by Liying Zhu, Longguang Dai, Nenghong Yang, Mi Liu, Shuang Ma, Chengcheng Li, Jie Shen, Tao Lin, Dan Wang, Wei Pan, et al.

    Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most frequent cause of cancer‐related death. The IRX5 transcription factor plays a different role in multiple cancers and contributes to the development of many tumours. However, little is known about the molecular mechanisms of IRX5 in HCC. In this study, we found that IRX5 was abnormally upregulated in HCC tissues compared with adjacent normal tissues. IRX5 promoted HCC cell proliferation and upregulated the expression of cyclin D1 and knockdown of IRX5 suppressed tumorigenicity in vivo. Furthermore, knockdown of IRX5 increased p53 and Bax expression and decreased Bcl‐2 expression. Thus, IRX5 suppressed apoptosis in HCC cells by inhibiting the p53 signalling pathway, indicating its role as a treatment target for HCC.Significance of the study: Our study demonstrated that IRX5 was abnormally upregulated in HCC tissues compared with adjacent normal tissues. IRX5 promoted HCC cell proliferation and upregulated the expression of cyclin D1, and knockdown of IRX5 suppressed tumorigenicity in vivo. Furthermore, knockdown of IRX5 increased p53 and Bax expression and decreased Bcl‐2 expression. IRX5 suppressed apoptosis in HCC cells by inhibiting the p53 signalling pathway, indicating its role as a treatment target for HCC.


  • Open Access

    LncRNA CRNDE promotes the epithelial‐mesenchymal transition of hepatocellular carcinoma cells via enhancing the Wnt/β‐catenin signaling pathway

    by Liying Zhu, Nenghong Yang, Guiqin Du, Chengcheng Li, Guoqi Liu, Shengju Liu, Yongjie Xu, Yanan Di, Wei Pan, Xing Li

    Colorectal neoplasia differentially expressed (CRNDE) is a significantly upregulated long noncoding RNA in hepatocellular carcinoma (HCC). CRNDE could promote cell proliferation, migration, and invasion, while its molecular mechanisms were still largely unclear. In this study, we investigated the expression and function of CRNDE. CRNDE was significantly upregulated in tumor tissues compared with adjacent normal tissues. In vitro, we revealed that knockdown of CRNDE inhibited cell proliferation, migration, and cell invasion capacities in HCC. Animal studies indicated that CRNDE knockdown represses both growth and metastasis of HCC tumors in vivo. Moreover, knockdown of CRNDE suppressed the cell epithelial‐mesenchymal transition (EMT) process by increasing the expression of E‐cadherin and ZO‐1, whereas, decreasing the expression of N‐cadherin, slug, twist, and vimentin in HCC cells. We also revealed that knockdown of CRNDE suppressed the Wnt/β‐catenin signaling in HCC. Thus, CRNDE could modulate EMT of HCC cells and knockdown of CRNDE impaired the mesenchymal properties. CRNDE increased invasion of HCC cells might be through activating the Wnt/β‐catenin signaling pathway.


  • Open Access

    Long noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR‐384

    by Liying Zhu, Nenghong Yang, Chengcheng Li, Guoqi Liu, Wei Pan, Xing Li

    It was reported that long non‐coding RNA nuclear‐enriched abundant transcript 1 (NEAT1) is involved in hepatocellular carcinoma (HCC). However, the underlying mechanism of tumorigenesis is still largely unclear. Here, we found that NEAT1 is remarkably upregulated in HCC tissues and cell lines. Overexpression of NEAT1 notably accelerated HCC cell proliferation, migration, and invasion. Knockdown of NEAT1 significantly inhibited HCC cell proliferation, migration and invasion. MiR‐384 expression was lower in HCC tissues and cell lines than adjacent nontumor tissues and L02 cell. MiR‐384 exhibited the functions of tumor‐suppressive. The expression of miR‐384 was negatively correlated with the expression of NEAT1. Overexpression of NEAT1 reduced miR‐384 expression, whereas inhibition of miR‐384 led to a distinct upregulation of NEAT1 expression. In addition, we provided evidence that miR‐384 was directly bound to the sequence of NEAT1 by luciferase reporter and RNA‐binding protein immunoprecipitation assays. Overexpression of miR‐384 inhibited NEAT1 function. Thus, we demonstrated that NEAT1 promotes the malignant biological properties of hepatocellular carcinoma by negatively regulating miR‐384.


  • Retracted
    Open Access

    RETRACTED ARTICLE: Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression

    by Shaoying Yan, Zhenrong Tang, Ke Chen, Yuyang Liu, Gangfeng Yu, Qiuxu Chen, Hao Dang, Fengjiao Chen, Jiaji Ling, Liying Zhu, et al.

    Background: Emerging evidences have indicated that long noncoding RNAs (lncRNAs) play essential roles in the development and progression of cancers. Dysregulation of lncRNA MIR31HG has recently been reported in several types of cancers, and researches on the function of MIR31HG in cancers suggested that MIR31HG could act as either oncogene or tumor suppressor. But the functional involvement of MIR31HG has not been studied in hepatocellular carcinoma (HCC). Methods: In this study, MTS assays, colony formation assay, Wound-healing assay, Transwell assy, and tumor xenografts experiments were used to identify biological effects of MIR31HG on HCC cells HCC proliferation and metastasis in vitro and in vivo. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to show the interactions of MIR31HG and miR-575. The bioinformatics methods were completed to find the target genes of miR-575. And Dual-luciferase reporter assay and Western blot analysis were further used to confirm the target gene of miR-575. Results: We found that overexpression of MIR31HG obviously suppressed HCC proliferation and metastasis in vitro and in vivo, whereas knockdown of MIR31HG had the opposite effects. Besides, overexpression of MIR31HG significantly decreased the expression of microRNA-575 (miR-575), which plays an oncogenic role in HCC. Moreover, dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay revealed that MIR31HG exerted tumor-suppressive functions by binding directly to miR-575, and there was a reciprocal inhibition between MIR31HG and miR-575 in the same RNA-induced silencing complex (RISC). Furthermore, overexpression of MIR31HG enhanced the expression of suppression of tumorigenicity 7 like (ST7L), which was identified as a downstream target gene of miR-575. Thus, MIR31HG positively regulated ST7L expression through sponging miR-575, and acted as tumor suppressor in HCC. Conclusions: Overall, our study illuminates the role of MIR31HG as a miRNA sponge in HCC, and sheds new light on lncRNA-directed diagnostics and therapeutics in HCC.